B. Riley Financial Cuts KindlyMD (NASDAQ:NAKA) Price Target to $0.50

KindlyMD (NASDAQ:NAKA) had its price target reduced by B. Riley Financial from $1.00 to $0.50 in a research note published on Monday,Benzinga reports. B. Riley Financial currently has a buy rating on the stock.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of KindlyMD in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $4.25.

KindlyMD Stock Up 12.5%

Shares of NASDAQ NAKA opened at $0.26 on Monday. The firm’s 50-day moving average price is $0.36 and its 200-day moving average price is $1.92. KindlyMD has a 52-week low of $0.23 and a 52-week high of $34.77. The company has a market cap of $113.09 million, a PE ratio of -0.23 and a beta of 31.46.

Institutional Investors Weigh In On KindlyMD

Hedge funds have recently modified their holdings of the business. Alyeska Investment Group L.P. bought a new position in KindlyMD in the 4th quarter worth $8,993,000. ParaFi Capital LP purchased a new stake in KindlyMD in the third quarter worth about $443,055,000. Hunting Hill Global Capital LLC purchased a new stake in KindlyMD in the fourth quarter worth about $4,672,000. RK Capital Management LLC FL bought a new position in shares of KindlyMD in the third quarter worth about $239,052,000. Finally, Yorkville Advisors Global LP purchased a new position in shares of KindlyMD during the 3rd quarter valued at about $231,942,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.